vs
阿普塔集团（ATR）与Grab Holdings Ltd（GRAB）财务数据对比。点击上方公司名可切换其他公司
Grab Holdings Ltd的季度营收约是阿普塔集团的1.5倍（$1.5B vs $962.7M），阿普塔集团净利率更高（7.7% vs 1.8%，领先6.0%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
Grab Holdings是总部位于新加坡纬壹科技城的跨国科技企业，旗下核心产品为移动端超级应用，覆盖网约车、外卖配送、数字支付等多元服务，业务布局新加坡、马来西亚、印度尼西亚、泰国、越南等共8个东南亚国家，是东南亚地区头部的本地生活及数字服务提供商。
ATR vs GRAB — 直观对比
营收规模更大
GRAB
是对方的1.5倍
$962.7M
净利率更高
ATR
高出6.0%
1.8%
损益表 — Q4 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.5B |
| 净利润 | $74.3M | $26.0M |
| 毛利率 | — | 43.1% |
| 营业利润率 | 11.0% | -2.5% |
| 净利率 | 7.7% | 1.8% |
| 营收同比 | 13.5% | — |
| 净利润同比 | -26.4% | — |
| 每股收益（稀释后） | $1.13 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRGRAB
| Q4 25 | $962.7M | — | ||
| Q3 25 | $961.1M | — | ||
| Q2 25 | $966.0M | — | ||
| Q1 25 | $887.3M | — | ||
| Q4 24 | $848.1M | $1.5B | ||
| Q3 24 | $909.3M | — | ||
| Q2 24 | $910.1M | — | ||
| Q1 24 | $915.4M | — |
净利润ATRGRAB
| Q4 25 | $74.3M | — | ||
| Q3 25 | $127.9M | — | ||
| Q2 25 | $111.7M | — | ||
| Q1 25 | $78.8M | — | ||
| Q4 24 | $100.9M | $26.0M | ||
| Q3 24 | $100.0M | — | ||
| Q2 24 | $90.5M | — | ||
| Q1 24 | $83.1M | — |
毛利率ATRGRAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 43.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ATRGRAB
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 14.9% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 14.2% | -2.5% | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 12.2% | — |
净利率ATRGRAB
| Q4 25 | 7.7% | — | ||
| Q3 25 | 13.3% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 11.9% | 1.8% | ||
| Q3 24 | 11.0% | — | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 9.1% | — |
每股收益（稀释后）ATRGRAB
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.92 | — | ||
| Q2 25 | $1.67 | — | ||
| Q1 25 | $1.17 | — | ||
| Q4 24 | $1.48 | $0.01 | ||
| Q3 24 | $1.48 | — | ||
| Q2 24 | $1.34 | — | ||
| Q1 24 | $1.23 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $3.0B |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $6.4B |
| 总资产 | $5.3B | $9.3B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRGRAB
| Q4 25 | $409.5M | — | ||
| Q3 25 | $264.8M | — | ||
| Q2 25 | $169.8M | — | ||
| Q1 25 | $136.8M | — | ||
| Q4 24 | $226.2M | $3.0B | ||
| Q3 24 | $327.9M | — | ||
| Q2 24 | $223.9M | — | ||
| Q1 24 | $201.1M | — |
总债务ATRGRAB
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
股东权益ATRGRAB
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.7B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.5B | $6.4B | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.3B | — |
总资产ATRGRAB
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $4.9B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.4B | $9.3B | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.5B | — | ||
| Q1 24 | $4.4B | — |
负债/权益比ATRGRAB
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $591.0M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | — |
| 自由现金流率自由现金流/营收 | 10.1% | — |
| 资本支出强度资本支出/营收 | 9.0% | — |
| 现金转化率经营现金流/净利润 | 2.47× | 22.73× |
| 过去12个月自由现金流最近4个季度 | $299.6M | — |
8季度趋势，按日历期对齐
经营现金流ATRGRAB
| Q4 25 | $183.7M | — | ||
| Q3 25 | $177.6M | — | ||
| Q2 25 | $126.0M | — | ||
| Q1 25 | $82.7M | — | ||
| Q4 24 | $178.2M | $591.0M | ||
| Q3 24 | $229.3M | — | ||
| Q2 24 | $143.6M | — | ||
| Q1 24 | $92.3M | — |
自由现金流ATRGRAB
| Q4 25 | $96.9M | — | ||
| Q3 25 | $114.3M | — | ||
| Q2 25 | $62.5M | — | ||
| Q1 25 | $25.9M | — | ||
| Q4 24 | $112.2M | — | ||
| Q3 24 | $162.7M | — | ||
| Q2 24 | $75.4M | — | ||
| Q1 24 | $16.7M | — |
自由现金流率ATRGRAB
| Q4 25 | 10.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 1.8% | — |
资本支出强度ATRGRAB
| Q4 25 | 9.0% | — | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 7.5% | — | ||
| Q1 24 | 8.3% | — |
现金转化率ATRGRAB
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | 22.73× | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
GRAB
暂无分部数据
